The shrub, Clerodenrum viscosum Vent. is traditionally used in the treatment of a number of diseases, including oxidative stress, inflammation, gastritis, burns, wounds, headaches, fever, jaundice, organ damage and so on. Oxidative stress and inflammatory events trigger cardiovascular diseases (CVD), which are one of the major consequences in health problems. The aim of the present study was to evaluate the possible clotlysis activity of C. viscosum leaf (MECVL). The hot MECVL was evaluated for anti-radical (DPPH: 1,1-diphenyl-2-picrylhydrazyl radical), egg albumin protection and inhibition of hemolysis of human erythrocytes (HRBCs), and clotlysis analysis, with ascorbic acid, acetyl salicylic acid and streptokinase as standards, respectively. Additionally, a preliminary phytochemical study was also conducted, which indicated the presence of alkaloids, glycosides, flavonoids, reducing sugars, and gums in MECVL. The MECVL concentration dependently scavenged the DPPH, inhibited protein denaturation, protected HRBCs and caused clotlysis. In the DPPH assay, MECVL at 100 μg/mL scavenged DPPH radical by 47.1 ± 0.8%. The highest activity was observed at the highest concentration of the MECVL (500 μg/mL), at which it inhibited protein denaturation, protected HRBCs and caused clotlysis by 81.5 ± 0.1, 89.4 ± 0.1 and 81.9 ± 4.8%, respectively. Although, in all cases, the standards exhibited better activities, but the effects of MECVL should be considered significant (p <0.05) in comparison to the negative control. The extract exhibited an anti-atherothrombosis capacity possibly via antioxidant, anti-inflammatory and membrane stabilization pathways, recommending C. viscosum as a promising phytotherapeutic tool.
Introduction
The use of plant products is increasing day by day. At present, thousands of plant metabolites are being successfully used in the treatment of a variety of diseases. According to an estimate, 80% of the world"s population is found to rely upon plants for medication [1] . For example, more than 47% of all drugs, used in Russia is obtained from plant sources [2] . In Bangladesh about 250 plant species are used in herbal medicines.
Clerodendrum viscosum Vent. is a slightly woody shrub (2-4 feet in height belonging to family family Verbenaceae. It is a terrestrial shrub having square, blackish stem and simple, opposite, decussate, petiolate, exstipulate, coriacious, hairy leaves with a disagreeable
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odour [3] . Flowers are bluish-purple often white in pyramid shaped terminal panicles. It has blunt quadrangular sterns and branches, leaves are usually three at a node, sometimes opposite oblong or elliptic, serrate, flowers are blue, many in long cylindrical thyrsus and the fruits are four lobed purple durpe, somewhat succulent with one pyrene in each lobe [4] . The plant prefers tropical habitat and commonly distributed throughout the plains of India, mainly in West Bengal [5] . It is known as "Hill glory bower" and "Clerodendrum" in English.
Different species of Clerodendrum genus have been traditionally used over centuries for their promising biological activities which include oxidative stress, inflammation, furunculosis, echymosis, gastritis, burns, wounds, headaches, dizziness, furuncles, hysteroptosis, dyspepsia, dropsy, fever, jaundice, typhoid, syphilis, gonorrhea, ophthalmia, antidiabetic, antibacterial, antimalaria, organ damage and so on [5] [6] [7] .
In Indian folk medicine, parts of C. viscosum are used in the treatment of bronchitis, asthma, fever, wound, blood disorders, inflammation, burning sensation and epilepsy. Various parts of the plant are used by tribes in colic, scorpion sting and snake bite, tumors and certain skin diseases. The leaves are slightly bitter, cure inflammation, skin diseases and small pox [7] . The bitter substance, clerodin is widely used as a tonic and an anthelmintic agent in the North India. The leaf extract is also reported for its haemsynthesis, anti-piles, anti-diabetic, and painkiller activities. Leaves and roots contain clerodolone, clerodone, clerodol, and a sterol now designated as clerosterol and are used for external applications on tumours [6, 7] . In a phytochemical study, C. viscosum revealed the presence of saponin, clerodin (a bitter diterpene). Leaves of the plant also contain fixed oils, while roots contain luperol, β-sitosterol, clerosterol (5,25 sigmastadien_3β-ol, clerodolone as lup_20(30)-en-3β-diol-12-one), clerodone (3β-hydroxylupan-12-one) and a steroidal glycoside [8] . C. viscosum is also evident to contain alkyl sterols, 2,- (3, 4- 
glycopyranoside (acteoside), triterpenes, steroids and flavonoids [7] .
A clot inside the blood vessel is called atherombosis, which is one of the major consequences of cardiovascular diseases.
Unfortunately, recently used antiatherothromboic drugs have a number of serious adverse effects [9] , which is a stimulation to search of new and safe agents. According to Pashkow, oxidative stress due to the overproduction of reactive oxygen and nitrogen species (ROS/RNS) triggers inflammatory and chronic human diseases, including aging and atherosclerosis [10] .
In previous studies, C. viscosum has been found to show organo-protective along with antioxidant and antiinflammatory capacities. Thus, this study was carried out to screen a possible anti-atherothrombosis effect of the crude methanol leaf extract of C. viscosum in human clotted blood. In this regard, after a preliminary phytochemical investigation, antioxidant and antiinflammatory capacities were re-evaluated along with a newly performed membrane stabilization test.
Materials and Methods

Research ethics
This study was conducted under the Department of Pharmacy, Southern University Bangladesh (SUB) with the ethical number #PH-9991010. For human blood, ten students of the same/different departments of the SUB willingly participated in this study. A specialist from a reputed diagnostic centre was invited to collect approximately 4-5 mL blood from each donor through venous puncture.
Plant collection, identification, drying and grinding
The whole plant was collected from the Batali Hill-Tracts (Chittagong), Bangladesh and was identified at Forest Research Institute (Chittagong), Bangladesh. A voucher specimen was deposited with the number: BFRIH-2034.
The leaves were washed with running tap water and subjected for shade-drying (temperature not exceeding 50 ᴼ C). Dried leaves were then ground into coarse powder with the help of a grinder and stored in an amber color airtight container until the extraction commenced.
Preparation of crude extract
Approximately 110 g of powdered materials was subjected to hot extraction with 700 mL of absolute methanol for 10 h using a Soxhlet extractor (Quickfit, England). The extract was then concentrated under an air cooler. The yield value was 15.89%.
Source of reagents and chemicals
The standards and the other necessary reagents and chemicals were purchased from the Sigma Chem Ex. Co. St. Louis, Missouri, USA.
Preliminary phytochemical analysis of the methanol extract of C. viscosum
Phytochemical study was conducted according to the methods described by Ali [11] .
Antioxidant capacity assay (DPPH radical scavenging test)
The test for DPPH scavenging activity was done by using a modified method described by Islam et al [1] . Briefly, 0.3 mL of sample was added to a 2.7 mL of ethanolic solution of DPPH (0.5 mM). After 30 min, the absorbance was measured using a spectrophotometer at 517 nm. A similar concentration of ascorbic acid (AA) served as the positive control, while only 0.3 mL methanol was considered as a negative control (NC) group. The blank contained no sample. The DPPH radical scavenging potential was calculated using the following equation:
Where, A br and A ar represent the before and after absorbance of DPPH in reaction mixtures, respectively.
Evaluation of anti-inflammatory activity (egg albumin denaturation test)
The anti-inflammatory (in vitro) of MECVL was carried out according to Ferdous et al [12] . Briefly, 1% egg albumin was constituted in phosphate buffer saline solution (PBS, pH 7.4). The assay mixture contains 1 mL phosphate buffer (pH 7.4, 0.15 M), 2 mL hypo-saline (0.36%) and 0.5 mL of the test sample. Acetyl salicylic acid (ASA) and distilled water (DW) were taken as positive and negative (NC) controls, respectively. After the incubation at 37 °C for 30 min, reaction mixtures were centrifuged and the supernatant was collected for spectrophotometric analysis at 560 nm. Activity was measured by the following equation: % inhibition of protein denaturation = 100 -[{(absorbance of test solution) ÷ (absorbance of NC)} × 100]
Evaluation of membrane stabilization capacity (HRBC assay)
This test was conducted by the hypo-saline induced hemolysis (HL) method described by Sultana et al [13] . In this occasion, fresh human RBC (HRBC) was reconstituted as 10% suspension in isosaline (0.9% NaCl, pH 7.4). The assay mixture contains 1 mL phosphate buffer (pH 7.4, 0.15 M), 2 mL hypo-saline (0.36%), 0.5 mL HRBC suspension (10% v/v) with 0.5 mL of the test sample. The ASA and DW were served as positive and negative controls, respectively. After incubation at 37 °C for 30 min, the reaction mixtures were centrifuged and the supernatant was collected for spectrophotometric analysis at 560 nm. Activity was measured by the following equation. 
Anti-atherothrombosis assay (Clotlysis test in human blood)
The thrombolytic activity of the MECVL was evaluated by the method of Ferdous et al [12] using streptokinase (SK: 100 IU) and previously mentioned NC, respectively. Briefly, blood was collected from 10 healthy volunteers and distributed into pre-weighed (W1) micro-centrifuge tubes (0.5 mL/tube) and incubated at 37 °C for 45 min and then weight (W2) was taken. The weight of clotted blood (ΔW) was obtained by subtracting the pre-weight and the weight of clotted blood containing tube. Then 100 μL of the treatments were added to the clot containing tubes marked. The MECVL was tested at concentrations of 125-500 μg/mL. On the other hand, 100 μL of streptokinase (100 IU/tube) and 100 μL of NC were added to the control marked tubes. All the tubes were then incubated at 37 °C for 90 min. After incubation, fluid released was removed carefully without disrupting the clot, and the tubes were again weighed for getting the weight variation among the pre-weight and final weight (W3) that was achieved for clotlysis.
Statistical analysis
Values are mean ± SD (standard deviation). The data were analyzed by means of analysis of variance (ANOVA) followed by t-Student-Newman-Keuls's as post-hoc test using the GraphPad Prism software (version 6.0) considering 95% confidence interval at p <0.05.
Results
Preliminary phytochemical analysis revealed the presence of alkaloids, glycosides, flavonoids, reducing sugars and gums ( Table 1) . Table 2 the MECVL showed significant (p <0.05) DPPH scavenging capacity in comparison to the NC group. However, the activity was lower than the AA (standard). The MECVL and AA at 100 µg/mL exhibited highest scavenging of DPPH by 47.1 ± 0.8 and 94.8 ± 1.1%, respectively. A concentration-dependent radical scavenging capacity was observed by the MECVL and AA. The NC produced a negligible DPPH scavenging capacity.
According to the
Both MECVL and the standard, ASA concentrationdependently inhibited protein denaturation capacity in egg albumin assay. At 500 µg/mL, MECVL and the ASA produced % inhibition of protein denaturation by 81.5 ± 0.1 and 89.1 ± 0.1%, respectively. In comparison to the NC group, the MECVL and ASA significantly (p <0.05) inhibited egg albumin denaturation. The half minimal inhibitory concentrations (IC 50 s) calculated for the MECVL and ASA were 127.7 ± 0.5 and 91.9 ± 0.6 µg/mL, respectively ( Table 3) . Table 4 indicates that, not only the ASA, but also MECVL concentration-dependently and strongly inhibited HL of HRBC when compared to the NC group. At 500 µg/mL ASA and MECVL exhibited HL inhibition by 92.2 ± 0.1 and 89.4 ± 0.1%, respectively. IC 50 s calculated for the MECVL and ASA were 123.8 ± 0.6 and 82.2 ± 0.6 µg/mL, respectively. Table 3 : Anti-inflammatory assay in egg albumin Table 4 : Membrane stabilization test in re-constituted human erythrocytes Table 5 suggests that, the MECVL has clotlysis capacity as compared to the NC group. The highest clotlysis capacity of the MECVL was observed with 500 μg/mL concentration of 81.9 ± 4.8%, while the standard drug, streptokinase (SK) by 84.5 ± 3.9% with 100 μL. The NC produced negligible clotlysis capacity.
Parameters
Discussion
Nevertheless, till date considerable attention has been given on plant-derived products. There is no doubt that, these kinds of medicaments are increasingly popular throughout the world. In fact, plant foods are one of the common daily consumption to us [14] . Previous phytochemical studies suggest that C. viscosum contains glycosides, flavonoids, steroids and some sugars. To date, seven sugars have been demonstrated in C. viscosum such as raffinose, lactose, maltose, sucrose, glactose, glucose and fructose [6, 7] . Our study demonstrates the presence of alkaloids, reducing sugars and gums along with the previously reported phytochemical groups.
Flavonoids are well-known for their promising biological activities, including immunomodulatory, anticancer, cytoand organo-protective, antidiabetic, and so on [14] . Phytochemicals containing active hydroxyl group (-OH), especially the essential oils and flavonoids may act as multi-edged sword in various diseases, and has been considered as perfect weapons in the treatment of diseases [15] . In our study, MECVL concentration-dependently exerted antioxidant and anti-inflammatory activities. Furthermore, it also exerted a strong membrane stabilization capacity in HRBCs. The determined IC 50 s, confidence interval (CI) and coefficient of determination (R 2 ) values suggest that MECVL has significant cytoprotective capacity. The AA and ASA are established antioxidant and anti-inflammatory agents, respectively. The AA can scavenge ROS and stimulate physiological defense systems, while ASA has a shunting effect on proinflammatory as well as inflammatory mediators. However, substance having radical scavenging and antagonistic capacity of inflammatory mediators may impart cellular protection. For example, the diterpene phytol is scavenged OH radical from the cell surface of Saccharomyces cerevisiae, thus protects them from OHinduced damaging effect. This diterpene is also protected rat erythrocytes from hydrogen peroxide-induced oxidative stress [14] . Moreover, examples of phytochemicals with antioxidant and anti-inflammatory capacities are vast [16] .
Throumbus formation inside the blood vessel obstacles the passages of required amount of oxygen and nutrients to the cells has been detected as one of the major consequences of cardiological complications, including stroke [9] . The SK is a widely used fibrinolytic drug, which binds and hydrolytically activities human plasminogen. The ultimate result is the clotlysis. On the other hand, oxidative stress due to the overproduction of reactive oxygen and nitrogen species (ROS/RNS) triggers inflammation and chronic human disease, including aging. The ROS/NOS-mediated oxidative stress can be identified in most of the key steps in the pathophysiology of atherosclerosis and the consequential clinical manifestations of cardiovascular disease as involves lipid metabolism, plaque rupture, thrombosis, myocardial injury, apoptosis, fibrosis and failure [10] . In this study, we found MECVL has a clotlysis capacity of human clotted blood. In comparison to the NC group, MECVL exhibited a significant (p <0.05) clotlysis capacity. The MECVL may act through either way.
Conclusion
The findings in phytochemical screening of MECVL are in agreement with of previous studies. MECVL concentration-dependently exhibited antioxidant, antiinflammatory, membrane stabilization and clotlysis activities. Antioxidant and anti-inflammatory-mediated cytoprotective effect may be linked to its membrane stabilization and anti-atherothrombosis effects. Further researches are required to isolate are welcomed to isolate and investigate responsible phytochemicals and their molecular mechanisms. 
